These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15095299)

  • 21. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma.
    Fautrel A; Andrieux L; Musso O; Boudjema K; Guillouzo A; Langouët S
    J Hepatol; 2005 Aug; 43(2):288-93. PubMed ID: 15922480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
    Kirschner K; Melton DW
    Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA repair gets physical: mapping an XPA-binding site on ERCC1.
    Croteau DL; Peng Y; Van Houten B
    DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.
    Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T
    EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleotide excision repair protein levels vis-à-vis anticancer drug resistance in 60 human tumor cell lines.
    Chen ZP; Malapetsa A; Monks A; Myers TG; Mohr G; Sausville EA; Scudiero DA; Panasci LC
    Ai Zheng; 2002 Mar; 21(3):233-9. PubMed ID: 12451985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular docking and molecular dynamics study on the effect of ERCC1 deleterious polymorphisms in ERCC1-XPF heterodimer.
    Priya Doss CG; Nagasundaram N
    Appl Biochem Biotechnol; 2014 Feb; 172(3):1265-81. PubMed ID: 24158589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer.
    Weberpals J; Garbuio K; O'Brien A; Clark-Knowles K; Doucette S; Antoniouk O; Goss G; Dimitroulakos J
    Int J Cancer; 2009 Feb; 124(4):806-15. PubMed ID: 19035454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin.
    Goldberg Z; Evans J; Birrell G; Brown JM
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):175-82. PubMed ID: 11163512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
    Selvakumaran M; Pisarcik DA; Bao R; Yeung AT; Hamilton TC
    Cancer Res; 2003 Mar; 63(6):1311-6. PubMed ID: 12649192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
    Fan W; Zhang HL; Wu XM
    Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms of nucleotide-excision repair genes may contribute to sperm DNA fragmentation and male infertility.
    Gu A; Ji G; Zhou Y; Long Y; Shi X; Fu G; Wang S; Song L; Wang X
    Reprod Biomed Online; 2010 Nov; 21(5):602-9. PubMed ID: 20864414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations and co-localizations of Hsp70 with XPA, XPG in human bronchial epithelia cells exposed to benzo[a]pyrene.
    Yang J; Liu X; Niu P; Zou Y; Duan Y
    Toxicology; 2009 Nov; 265(1-2):10-4. PubMed ID: 19748547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH.
    Saijo M; Matsuda T; Kuraoka I; Tanaka K
    Biochem Biophys Res Commun; 2004 Sep; 321(4):815-22. PubMed ID: 15358100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
    Boulikas T
    Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy.
    Klatte T; Seitz C; Rink M; Rouprêt M; Xylinas E; Karakiewicz P; Susani M; Shariat SF
    J Urol; 2015 Nov; 194(5):1456-62. PubMed ID: 26162296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins.
    Park CH; Sancar A
    Proc Natl Acad Sci U S A; 1994 May; 91(11):5017-21. PubMed ID: 8197175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors.
    Evans E; Moggs JG; Hwang JR; Egly JM; Wood RD
    EMBO J; 1997 Nov; 16(21):6559-73. PubMed ID: 9351836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific association between the human DNA repair proteins XPA and ERCC1.
    Li L; Elledge SJ; Peterson CA; Bales ES; Legerski RJ
    Proc Natl Acad Sci U S A; 1994 May; 91(11):5012-6. PubMed ID: 8197174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.
    Fadda E
    Biophys J; 2013 Jun; 104(11):2503-11. PubMed ID: 23746523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.